|
Ye.A. Yermakova, I.I. Kochergina
Features of course of arterial hypertension in patients with type 2 diabetes mellitus, its role in the development of vascular complications
|
№5 / 2017
|
|
A.G. Yevdokimova, Ye.S. Kiparisova, Ye.V. Kovalenko, V.V. Yevdokimov, L.I. Markova, K.I. Tebloev, I.V. Larina, A.I. Martynov
Рrevention and treatment of cognitive disorders in patients with hypertensive encephalopathy
|
№4 / 2017
|
|
A.G. Yevdokimova, Ye.V. Kovalenko, V.V. Yevdokimov, O.A. Shuiskaya
Potentials for the use of diuretic therapy in the clinic of internal diseases
|
№2 / 2017
|
|
M.Kh. Kurdanova, A.I. Martynov, I.A. Beslaneev, L.M. Batyrbekova, Kh.A. Kurdanov
System analysis of endothelium dysfunction in patients with arterial hypertension, the inhabitants of the highlands
|
№1 / 2017
|
|
A.N. Kuznetsov, N.Yu. Grigorieva, T.P. Ilyushina, M.B. Mayorova
Is there a relationship between bronchial asthma and arterial hypertension?
|
№1 / 2017
|
|
A.G. Yevdokimova, V.V. Yevdokimov, Ye.V. Kovalenko, K.I. Tebloyev
Clinical efficacy of fixed-dose combination antihypertensive therapy (focus on Hypotef)
|
№6 / 2016
|
|
V.A. Baturin, A.I. Elkanova
Pharmacoepidemiological study of ethnic differences in the use of antihypertensive drugs for hospital treatment of residents of the Karachay-Cherkess Republic
|
№5 / 2016
|
|
V.V. Cheltsov
Torasemide and furosemide: similarities and differences
|
№5 / 2016
|
|
S.N. Tolpygina
Place of eplerenone in the therapy of cardiovascular diseases
|
№5 / 2016
|
|
A.I. Martynov, Ye.V. Akatova, O.P. Nikolin, I.V. Urlaeva
Influence of magnesium orotate on cardiovascular risks
|
№5 / 2016
|
|
Ye.N. Dudinskaya, O.N. Tkacheva
Prospects for the use of moxonidine (Physiotens®) in the prevention of bone resorption and aging of the vascular wall
|
№4 / 2016
|
|
V.V. Cheltsov, Yu.Sh. Gushina, T.S. Illarioniva, E.А. Korovyakova, A.E. Moiseeva, A.P. Pereversev, Ye.Yu. Stefanenko, S.K. Ziryanov
Angiotensin II receptor blockers: focus on cardesartan
|
№4 / 2016
|
Русский
